News ArticleEndurance Technologies Posts ₹213.48 Crore Profit for Q2 FY2027 on ₹3,752.73 Crore Revenue
Company’s half-year profit reaches ₹408.10 crore on ₹6,935.44 crore revenue; unaudited standalone results for Sept 30, 2026 period announced
Endurance Technologies Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September 2026, reporting a profit of ₹213.48 crore for Q2 on revenues of ₹3,752.73 crore and a half-year profit of ₹408.10 crore on revenues of ₹6,935.44 crore, reflecting operational performance in line with prior periods.
Endurance Technologies Limited
Financial Results
Endurance Technologies Limited reported its standalone unaudited financial results for the quarter and half year ended 30th September 2026, registering a Q2 profit of ₹213.48 crore on ₹3,752.73 crore revenue and a half-year profit of ₹408.10 crore on ₹6,935.44 crore revenue.
For the quarter ended 30th September 2026, total income was ₹3,761.22 crore compared to ₹2,692.22 crore in the same quarter last year, and profit before tax stood at ₹287.82 crore.
Expenses for the quarter included ₹2,717.55 crore in material costs and ₹579.78 crore in other expenses, contributing to a total expense of ₹3,473.40 crore.
The half-year ended 30th September 2026 showed revenues of ₹6,935.44 crore and profit before tax of ₹548.17 crore, with tax expenses totaling ₹140.07 crore.
Earnings per share for the quarter were ₹15.18 (basic and diluted) versus ₹13.33 in the previous year quarter, and ₹29.01 for the half-year compared to ₹25.12 last year.
The balance sheet as of 30th September 2026 recorded total assets of ₹7,079.31 crore with equity share capital of ₹140.66 crore and other equity of ₹5,050.30 crore.
Highlights
- Q2 standalone profit: ₹213.48 crore
- Q2 revenue: ₹3,752.73 crore
- Half-year profit: ₹408.10 crore
- Half-year revenue: ₹6,935.44 crore
- Earnings per share Q2: ₹15.18
- Total assets at Sept 30, 2026: ₹7,079.31 crore
Key Data Snapshot
What happened
- Endurance Technologies approved its standalone unaudited financial results for quarter and half year ended 30th September 2026.
- The company reported a profit after tax of ₹213.48 crore for the quarter.
- Revenue from operations for Q2 stood at ₹3,752.73 crore.
- Earnings per share for the quarter was ₹15.18 (basic and diluted).
Financial performance
- Total income for the quarter was ₹3,761.22 crore with expenses totaling ₹3,473.40 crore.
- Profit before tax for the quarter was ₹287.82 crore.
- For the half year, total income was ₹6,955.37 crore with profit before tax ₹548.17 crore.
- Tax expense for half year was ₹140.07 crore resulting in net profit of ₹408.10 crore.
Key details
- Cost of materials consumed during Q2 was ₹2,717.55 crore, a significant portion of expenses.
- Balance sheet as on 30th September 2026 showed non-current assets of ₹3,544.91 crore and current assets of ₹3,534.40 crore.
- Equity share capital remained ₹140.66 crore with other equity at ₹5,050.30 crore as of 30th September 2026.
- Total liabilities including financial liabilities and provisions summed to ₹1,888.15 crore.
Next milestones
- The trading window for dealing in company securities opens on 6th November 2026, 48 hours post announcement.
- Further updates on annual audited results expected in line with statutory timelines.
Highlights
- Q2 standalone profit: ₹213.48 crore
- Q2 revenue: ₹3,752.73 crore
- Half-year profit: ₹408.10 crore
- Half-year revenue: ₹6,935.44 crore
- Earnings per share Q2: ₹15.18
- Total assets at Sept 30, 2026: ₹7,079.31 crore
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Biocon Limited Reports Rs. 1,439 Million Profit for H1 FY2026-27; Appoints Mukesh Rathi as New CTO from January 2027
Biocon Limited declared its unaudited standalone financial results for the quarter and half-year ended September 30, 2026, reporting a profit of Rs. 1,439 million for the half-year. Alongside financial disclosure, the company announced a change in its senior management with the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as the new CTO starting January 1, 2027.
Read Full Story
Zydus Lifesciences Posts ₹10,541 Million Net Profit for Half Year Ending September 30, 2026
Zydus Lifesciences Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording a net profit of ₹7,145 million for Q2 and ₹10,541 million for the half year.
Read Full Story
Fractal Analytics Limited Reports Unaudited Q2 and H1 2026 Financial Results and Approves Winding Up of Analytics Vidhya Inc
Fractal Analytics Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. Additionally, the company's Board has approved winding up its step-down subsidiary Analytics Vidhya Inc., aiming to simplify group corporate structure and enhance operational efficiency without affecting ongoing business activities.
Read Full Story
